BeOne Medicines

10/16/2026

AI is reshaping the future of cancer care. Patients and advocates must have a seat at the table from the start.

We recently welcomed more than 50 patients, advocates and leaders from across healthcare and technology to our Hopewell campus for BeOne’s Patient Advocacy Leadership Summit on AI in Cancer Care.

Together, we tackled some of the biggest questions surrounding AI in cancer care: How do we build trust? Protect access? Preserve human judgment? And how do ensure that patients and patient advocacy groups have a voice in how these technologies are developed and used?

One message came through clearly: Realizing AI's full potential will take collaboration, accountability and a shared commitment to keeping patients at the center.

This was just the beginning. The future of AI in cancer care is still being written, and we all have a role in shaping what comes next. Let’s build it together!

If you joined us at the summit, share the organization or patient community you represented in the comments.

10/14/2026

🌅 CLL Horizons 2026 is here!

This Friday, the global CLL community gathers in Barcelona for three days of learning, connection and collaboration under this year’s theme: Strength in Science, Power in Community.

🔬We are excited to hear from clinicians, researchers and patient advocates as they share the latest breakthroughs in CLL, explore new questions in care and research, and discuss what these advances mean for people living with CLL.

But Horizons is about more than sessions.

It is about the conversations in between: reconnecting with old friends, welcoming new faces, exchanging experiences and uniting diverse perspectives.🧡

🤝Together, we’ll shape the future of CLL advocacy and care.

See you in Barcelona!

📍 16–18 October 2026

10/02/2026

We're just over a month out from our 14th Powwow for Hope, relatives! We're excitedly finalizing details and looking forward to gathering with everyone.

This event wouldn't be possible without our amazing sponsors, like our friends at BeOne Medicines who stepped up as our presenting sponsor this year.

BeOne Medicines is a global oncology company that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide, and we are so grateful for their partnership and dedication to supporting the work we do in Indian Country. ❤️🙌

09/29/2026

“We are getting a better understanding of the tumor…and there's something very unique about HER2.”

Dr. Jaffer Ajani shares his insights on how advances in cancer therapies have transformed the treatment landscape for patients, and why continued innovation in is so important.

Check out the latest installment of Expert Answers in HER2+ Gastroesophageal Cancer to learn more.

Learn more: https://bit.ly/4e5Krma

09/23/2026

Scientific progress has transformed what’s possible for people living with chronic lymphocytic leukemia (CLL). But the healthcare system has failed to keep pace with science.

Too many patients still face gaps in biomarker testing, CLL expertise, care coordination, insurance coverage and more that stand between them and the latest advances in CLL care.

That’s why we partnered with Charles River Associates and the broader blood cancer community on a first-of-its-kind national assessment of the CLL care ecosystem: When Innovation Outpaces Access: Closing the Gap in CLL Care.

The report outlines five actions to help more patients receive the right treatment at the right time:

✅ Expand access to biomarker testing
✅ Improve access to scientifically accurate information
✅ Connect more patients to CLL expertise
✅ Reduce insurance barriers that delay or deny treatment
✅ Increase transparency and promote responsible AI in cancer care

Learn more and download the full report: https://bit.ly/4ALYA1V

09/21/2026

Learning about biomarkers can feel overwhelming after a diagnosis of .

Dr. Manish Shah explains what biomarkers are and why testing for them is an important step in treatment planning.

Check out the latest episode of Expert Answers in HER2+ Gastroesophageal Cancer.

Learn more: https://bit.ly/3SXpWkB

09/14/2026

BeOne is proud to support CLL Society Inc.’s upcoming Celebrating Long Lives 5K Walk/Run, bringing the CLL/SLL community together across the nation in support of patients and care partners.

As we recognize , we’re proud to stand alongside the CLL/SLL community and organizations working to make a difference for patients and their families.

Learn more and register below!

September is Blood Cancer Awareness Month, and every step you take on Saturday, September 26th, for the Celebrating Long Lives Virtual 5K helps raise awareness and support for the CLL/SLL community.

"I am so grateful for the CLL Society. It has kept me informed, supported and sane both before, and during my treatment. I'm sure they will support me long after as well, as CLL is not curable and something I will live with for years to come." — Sara N., on our community page

Whether you walk a neighborhood loop, a park trail, or your favorite local spot, you're walking for someone. Register today, then leave your own message on the community page telling us why you're walking. Your story might be exactly what inspires someone else to register.

https://charity.pledgeit.org/CLL5K26

09/14/2026

After nearly two decades of treating patients, Dr. Yelena Janjigian reflects on the remarkable progress she has witnessed in the treatment of and how it is changing what's possible for patients today.

Check out this installment of Expert Answers in HER2+ Gastroesophageal Cancer to hear her perspective.

Learn more: https://bit.ly/3SZ3qaX

09/10/2026

Blood cancer care is evolving rapidly, creating new possibilities for patients and clinicians, and no two chronic lymphocytic leukemia (CLL) journeys are the same.

For some people, what matters most is continuing to do the things they love. For others, it's about staying independent, spending time with family, or feeling reassured about what comes next.

Whatever matters most, every person's experience is unique.

That's why, in partnership with CLL Advocates Network, we're launching No Patient Like Me. Through patient stories and practical resources, the program aims to help ensure that individual needs, goals, and preferences remain part of the conversation in CLL care.

Learn more: https://bit.ly/4h3uCNK

09/02/2026

No two blood cancer journeys are the same.

Disease biology, risk factors, personal priorities, and treatment goals all shape the choices patients and physicians make throughout the care journey.

This , we’re highlighting the importance of understanding the individual behind every diagnosis and continuing to advance more personal blood cancer care.

Learn more: https://bit.ly/4xsIo3k